Shay Capital’s Tectonic Therapeutic TECX Stock Holding History

Shay Capital’s Portfolio TECX Stock Details TECX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-833	Closed	-$10K	–	604
2023 Q1	$10K	Buy	+833	New	+$11.6K	﹤0.01%	413

Other funds holding TECX

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Shay Capital's TECX Position: Q2 2023 in Review

Shay Capital sold out of Tectonic Therapeutic (TECX) in Q2 2023, closing a stake of 833 shares — an estimated $10K sold.

Shay Capital first reported a position in TECX in Q1 2023 and held it in 1 quarter. The position peaked at $10K in Q1 2023. 40 funds tracked by Wall St. Rank hold TECX as of Q2 2023.

Shay Capital reported no remaining Tectonic Therapeutic position as of Q2 2023 after selling out during the quarter.
Shay Capital sold 833 Tectonic Therapeutic shares in Q2 2023, an estimated $10K.
Shay Capital first reported a position in Tectonic Therapeutic in Q1 2023 and held it in 1 quarter.
Shay Capital's Tectonic Therapeutic position peaked at $10K in Q1 2023.
40 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2023.

Based on Shay Capital's 13F filing for Q2 2023, filed 14 Aug 2023.